Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exparel Versus Bupivacaine in Post-operative Pain Control Following Bilateral Third Molar Extractions: A Single-blind Randomized Clinical Trial

NCT06547255 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT06547255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exparel Versus Bupivacaine in Post-operative Pain Control Following Bilateral Third Molar Extractions: A Single-blind Randomized Clinical Trial
Lead sponsor
Case Western Reserve University
Phase
Phase 4
Overall status
Completed
Start date
August 21, 2024
Completion date
July 1, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liposomal bupivacaine